PARC NORMAN ANSES - European Partnership for the Assessment of Risks from Chemicals 02/12/2020 - THE NORMAN NETWORK
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
European Partnership for the Assessment of Risks from Chemicals PARC Horizon Europe candidate Partnership NORMAN 12th General Assemby 02/12/2020 ANSES European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
What is a Horizon Europe Partnership Co-Construction European Commission/Member State European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
Context for the PARC proposal Challenges: Risk assessment agencies and Opportunity: Horizon Europe regulatory bodies and associated research A partnership to boost research and innovation community in the EU are confronted with in support of chemical risk assessment Øpersistent science-regulatory gap Responding to policy priorities: Øgaps in knowledge of and information on hazards, SDGs, 2019 Council Conclusions, Green Deal, Towards a Øoccurrence and exposures to chemicals and mixtures Sustainable Chemicals Policy Strategy … Øscattered and non-accessible evidence Requirement: Øscreening, testing and assessment methods to be A joint research and innovation roadmap set by risk developed, validated and taken-up assessors & managers in consultation with academia, Øduplication of efforts and inefficient use of resources association, industry and other stakeholders Øinsufficient risk communication Worked on it with a Steering Group (Sept 2019-Nov 2020): 25 countries: AT, BE, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GR, HR, HU, IS, IT, LV, LU, NL, NO, PL, PT, SE, SI, SK And ECHA, EEA, EFSA, JRC, DG R&I, DG SANTE, DG ENV, DG GROW & others Concept paper published early June 2020: Provides an overview of the context, objectives and expected impacts and the planned implementation with the suggested structure, activities and governance European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
Setting the scene European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
Concept paper European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
Description of the objectives-oriented organisation European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
Key Performance Indicators European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
Prioritisation process 2 Surveys: PARC / HBM4EU • Online survey on priorities for work on 22 June- chemical risk assessment Survey on PARC priorities 18 Sept • 156 entries Survey on substances for human biomonitoring • 21 Sept – present proposed process to the • 36 entries 21 Sept interim WP leaders Supporting 2020 WPs •Q1. Overall knowledge needs WP4 Monitoring •Q2. Priorities for monitoring & exposure Oct/Nov • Analysis by interim WP leaders and exposure WP5 Hazard 2020 assessment •Q3. Priorities for hazard assessment Implications for WP7 on WP6 Innovation in •Q4. Priorities for innovation in chemical data and WP9 • Consult interim Country Board, EU Board, regulatory RA risk assessment on capacity Nov/Dec Grant Signatory Board WP8 building 2020 Concepts & •Q5. Priorities for new concepts and tools toolboxes Supporting •Q6. Additional priorities and references WPs European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
Objectives-oriented structure European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
WP4: Monitoring and exposure Interim WPL: UBA (DE), SpF(FR) Interim Team: VITO (BE), ISCIII (ES), AU (DK), INERIS(FR), EEA (EU), INRAE (FR), VU-EH (NL), MUI (AT), EFSA (EU) 4.1 Human • Alignment and harmonisation of HBM programmes Biomonitoring 4.2 Environmental and • Multiple sources, chemical fates and environmental exposure pathways of multisource chemicals monitoring • Long term and life cycle stages associated exposure • Environmental monitoring in support of the regulatory framework 4.3 Innovative • Non-targeted screening and emerging chemicals methods and tools for • Characterise mixtures for exposure assessment monitoring and • Link exposure and health related information surveys • Relevance • Needs • Activity planning • Costs European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
WP5: Hazard assessment Interim WPL: ANSES (FR), BfR (DE) Interim Team: NIPH (NO), VUB (BE), DTU (DK), INSERM (FR), INSA (PT) Adverse outcomes (non-genotoxic) Degradation products PFAS & precursors Substances Carcinogenicity Genotoxicity BPA alternatives Endocrine disruption 5.1 Toxicity testing Conduct of 90-d GL studies Conduct of 90-d GL studies addressing data gaps Toxins Neurotoxity with single substances and‚ with toxins; (relevant of concern DNT real life‘ mixture; simultan mixtures) simultan analysis Materials Immunotoxicity analysis of classical of classical parameters and Reproductive & parameters and omics omics analysis; simulation. Nano, µ plastics Developmental toxicity techniques; simulatn. analysis of kinetics nanomaterials Specific organ toxicity analysis of kinetics Ecological risks 5.2 Innovative In vitro screening of DBP, co- In vitro screening of toxins, methods and tools for formulants; cell painting; cell painting; cytotox; HCS, Overarching topics toxicity testing and cytotox; HCS, reporter reporter genes, enzyme Combinatorial effects/mixtures modelling genes, enzyme interactions interactions; AOP Grouping development QSAR/Read across 5.3 Regulatory use of In vitro kinetic interactions In vitro kinetic interactions Systems biology hazard data (in E.g.CYP inhibition+induction E.g. CYP collaboration with TK/PBPK nhibition+induction 6.1) • Relevance • Needs • Activity planning • Costs European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
WP6: Innovation in regulatory risk assessment Interim WPL: RVM (NL), KEMI(SE) Interim Team: UL-LACDR (NL), Sciensano (BE), VITO (BE), ANSES (FR), EFSA (EU), BPI (EL), ACES (SE), UNIBAS (CH) WP6.1 Integrative • Development and testing of IATAs for regulatory purposes approaches to testing and • Development and/or expansion of (quantitative) Adverse Outcome Pathways assessment (IATA) • Identification and validation of effect biomarkers • Development of a workflow for assessing the human relevance of AOPs, as well as the relevance of associated test methods and tools • Pre-validation of test methods used in IATA • Development of computational modelling approaches for integrating outputs from non-animal methods and tools towards quantitative hazard assessment • Evaluation of IATAs, using weight of evidence approaches for integrating human data and data from traditional and novel (test) methods and including characterisation of uncertainty WP6.2 Integrative • Mixture risk assessment • Linking internal exposure to external aggregate exposure exposure and risk • Aggregate exposure from different Sources of and vice versa assessment exposure Routes • Ecological risk assessment WP6.3 Review of risk • Tools to help enforcement of legislation with focus on articles assessment methodology • Develop a decision support system WP6.4 Transposing results • Efficient risk assessment processes to regulatory risk • Develop regulatory and legally accepted risk assessment and management methods for for chemical mixtures, assessment methodologies • for articles in circular material flow, complex situations with severe knowledge gaps • Facilitate the regulatory acceptance and use of new methods • Research to support the inclusion of new endpoints in chemical regulation to increase the protection of biodiversity, including the integrity and resilience of ecosystems European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
WP2: A common science policy agenda Interim WPL: EEA(EU), EAA (AT) Interim Team: ANSES (FR), ECHA (EU), EFSA (EU), INSA (PT), BfR (DE), NPHC (HU), Inserm (FR) Collaboration with all WPs • Evaluation and uptake of first • Developement and • Support drafting survey implementation of a of the 3 year Regular consultations 2.1 Priority setting Drafting the first research and prioritisation strategy strategic agendas • • Governing Board innovation agenda • 2022-2024 • Scientific communities • Develop a process to ensure • Develop a format for dialogue • Stakeholders the immediate access of risk between assessors / Managers [Early partnership/regulatory Close collaboration Warning System] scientists and EU Institutions National Hubs, EUHUb • Compile existing knowledge • Develop an appointment • Develop and define data gaps to process for Chemical Leaders workflows to 2.2 Knowledge addressed (CLs) and New Approach achieve the management and • Map list of ongoing activities by Methodologies’ Leaders objectives uptake into policies regulatory bodies, OECD work (NAMLs) identified in the exit strategy • Guarantee open access and fair • Develop a proposal for data consistent and coherent information flow • Mapping of needs of national • Concept for capacity building • Exit Strategy hubs & establish a peer to peer 2.3 Sustainalibilty learning activity process together with WP9 European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
WP3: Synergies, collaborations and awareness Interim WPL: INSA (PT), GSCL (EL) Interim Team: EAA (AT), ECHA (EU), EFSA (EU) 3.1 Stakeholders Set-up of the International Board, Running of the International Board forum and Stakeholder Forum and nomination of and Stakeholder Forum international board the PARC Ambassador 3.2 Communication Development of a graphical identity for Establishment of synergies and and dissemination PARC collaborations with national, EU- Website and channels in social media level and international activities Development of a communication and Outreach activities and awareness dissemination strategy raising European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
WP8: Concepts and tools Interim WPL: AUTh (EL) Interim Team: EMPA (CH), UF2N (IT), RIVM (NL), WR-Bio (NL), KEMI (SE) 8.1 Safe and • Key protection goals and implementation criteria Development of a SSBD assessment toolbox sustainable • Develop conventions for the terms ‘safe’ and § Describe methods with which critical properties by design ‘sustainable’ in relation with the key protection goals (such as toxicity, exposure) of chemicals in function of usage (reparability, reusability, recyclability) § Develop guidelines for the toolbox implementation, following OECD recommendations 8.2 Early • Identification of the needs and user requirements for • Development of the computational framework warning an early warning system to support the early warning system). system • Enable searches in chemical inventories on their • Develop guidelines for the toobox potential of being new emerging risk chemicals implementation (OECD recommendations) (NERC), • Relevance • link with development in Non Targeted Screening • Needs analysis • Activity 8.3 Development of the toolbox for integrative modeling of Toolbox implementation based on cloud computing planning Integrative exposure and risk assessment and application programming interfaces (APIs) • Costs models • Mobility in the environment, accounting for their overall environmental fate Case studies using the integrative modeling toolbox • Exposure pathways and routes • Toxicity potency, using QSARs and other computational methods developed in WP5 • Identify whether they will be potential NERCs European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
WP7: FAIR Data Interim WPL: VITO (BE), TNO (NL) Interim Team: MU (CZ), EFSA (EU) UU-IRAS (NL), support by JRC, DG ENV European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
WP9: Capacities and networks Interim WPL: MU (CZ), ISCIII (ES) Interim Team: Capacities Capacity Mapping and Strengthening Laboratory Networks Cooperation raining Standardisation of approaches ¨. x a m ples of t le Severa et to pics o su res (targ Training Development of templates and questionnaires to identify the training s of ex p analyse , needs and relevant groups of stakeholders beyond the Partnership S) and NT s of related lth Collection and management of needs identified in other WPs within analy s e n ta l a nd hea me expert working groups comprising experts from WP 4-8 representatives environ s, effect risks, Implementation of the needs via s es s m ent of analysis of as t a n d emen • Organisation of (on-line) training activities manag etc d ata, e of models • preparation of annual (on-line) training programmes within and beyond ing, u s modell Partnership • development of online materials • development or adaptation of guidance on training programmes and harmonisation procedures • organisation of periodical seminars • Needs by activity Collaboration with education sector and national hubs • Design Training programme Dissemination of training materials and training programmes (in cooperation • Implementation with WP3) • Monitoring European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
Link to EU Chemicals Strategy for Sustainability – published 14/10/2020 Encourage innovation Promote the development of safe and sustainable chemicals and materials, clean production processes and technologies, innovative tools for testing and risk assessments. • Contribute to the development of EU criteria Ø Safe and sustainable chemicals (WP8) Ø Early Warning System (WP8, WP4) Ø Mixtures assessment factors (WP6, WP8) Ø Environmental risk assesments (WP6) • Development of Ø innovative tools (WP4,5,6, 8) Ø methodologies that take into account the whole life cycle of substances, materials • Development and uptake of methods to generate information on endocrine disruptors through screening and testing of substances (WP5, 6) • Contribute on the methodologies and data (WP5, 7) European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
Partnership implementation strategies 7-year Description of Action 3-year common 3-year common Common / exit strategy strategy strategy Annual Annual Annual Annual Annual Annual Annual Work Work Work Work Work Work Work Plan Plan Plan Plan Plan Plan Plan European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
Construction process of the Partnership Sept Oct Nov Dec Jan Feb Mar Apr May June 2020 2020 2020 2020 2021 2021 2021 2021 2021 2021 Description of actions By WP SRIA Challenges Planning of activities Proposal Identification of challenges to Targets/Objectives be addressed Expected outputs 3Y common Strategy Near future (1-3Y) - Precise Task and deliverable List of detailed activities Long term (4-7Y) - General description Precise work based on WP/T (similar to the concept paper) related to DoA 1st annual work plan • Consultation GB • EU Call • Priorities • Concept paper • Interim MB questionnaire • National commitments • GSB/LTP • Interim MB SRIA: Strategic Research and • Steering Group • GB Innovation Agenda • GSB/LTP WP/T: Worpackage and Tasks DoA: Description of Action • GB European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
Roadmap for the next steps – 2021 1 Dec • First meeting of the GB/GSB to discuss priorities 2020 Dec - • Interim WP co-leaders translate the priorities into the 3-year common strategy and first annual March work plan for the Partnership 2021 March- • Second meeting of the GB/GSB to adopt the final 3-year common strategy, the 1st annual April work plan 2021 April • Publication of the Work Programme 2021-2022 by the EC 2021 TBC • Preparation of the proposal submission: administrative, technical and budgetary data and CA April- preparation June June- • Submission of the complete proposal to the Commission Aug TBC Aug-Nov • Evaluation by the European Commission TBC • Contractual process: Verification, signature of the administrative forms, preparation of the Nov-Dec 2021 Kick-off meeting Jan 2022 (TBC) : Launch of the Partnership and kick off meeting in France (under French presidency of the Council of the EU) European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
Conclusion Objectives of NORMAN are in line with PARC objectives. Joint data space and cutting-edge research tools for Risk assessment of contaminants of emerging concern Advanced data analysis tools: NORMAN & PARC networks are connected towards a European Early Warning INERIS system UBA ◦ Prioritisation of substances and WUR priority setting AU Support to national and European SWACCS chemical risk asessment: MU harnessing, combining and sharing AUTh evidence and expertise on CECs BRGM INRAE RIVM ….. European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
Project contact details Coordination team: PARC email box: parc@anses.fr Adrienne Pittman: adrienne.pittman@anses.fr Pascal Sanders: pascal.sanders@anses.fr Philippine de Barbeyrac: philippine.debarbeyrac@anses.fr European Partnership for the Assessment of Risks from Chemicals – NORMAN General Assembly 2 December 2020
You can also read